LINC00511 functions as an oncogene by attaching to the histone methyltransferase, enhancer of zeste homolog 2 (EZH2), and inhibiting p57 in non-small cell lung cancer (NSCLC) [180]. Here, PRDM9 is linked to non-small cell lung carcinoma.